As global populations grow at an unprecedented rate, alongside the rising prevalence of diseases such as diabetes, kidney failure, and cardiovascular conditions, the demand for advanced medical care and treatment has become an urgent global imperative. In this critical landscape, the development and commercialization of cutting-edge medical device technology are essential to meeting these challenges.
BIOVIC stands at the forefront of this mission, offering not only a pipeline of innovative, high-quality medical products but also delivering significant value-added benefits. By prioritizing affordability, conducting targeted market research, and ensuring availability, BIOVIC is committed to enhancing the quality of life for the communities it serves.
The prestigious BioNexus status is granted to distinguished international and Malaysian biotechnology companies engaged in impactful biotechnology and life sciences initiatives, recognizing their contributions to advancing healthcare and innovation.
BIOVIC is committed to designing, developing, and commercializing medical devices that not only meet but exceed the expectations of our customers, regulatory standards, and all relevant requirements. With unwavering dedication, we will ensure the continuous suitability and effectiveness of our quality system, setting a new standard for excellence in the medical device industry.
Tarun Edwin brings over 25 years of unparalleled expertise in the Biomedical industry, cementing his reputation as a distinguished Biomedical Engineer. Throughout his illustrious career, he has been the driving force behind the conception, design, development, and commercialization of numerous groundbreaking biomedical devices. An inventive force in the field, Tarun holds 37 patents with additional patents pending, showcasing his relentless pursuit of innovation.
His specialization lies in the development of ePTFE-based vascular grafts and stent grafts, where he has demonstrated exceptional proficiency. Having worked with multiple leading U.S. companies, Tarun has contributed extensively across Manufacturing, Research & Development, New Technology Development, and Intellectual Property sectors.
In his role as Senior Program Manager at Bard Peripheral Vascular, he led high-performing teams that secured 510k clearances for over five medical devices, alongside one highly complex IDE-PMA submission. As a project manager and lead biomedical engineer, he spearheaded the creation of pioneering products such as the Venaflo™ and Distaflo™ ePTFE grafts, and was the visionary behind the Bard Flair™ and Fluency™ stent grafts.
In recognition of his exceptional contributions to the company, Tarun was honored in 2004 as the most prolific inventor at Bard, and was bestowed with the prestigious C.R. Bard “Scientific and Technology Achievement Award.” His academic credentials further exemplify his commitment to excellence, with degrees that include:
Bachelor of Science in Electrical Engineering, Southern Illinois University
Bachelor of Engineering in Biomedical Engineering, Arizona State University
Master of Science in Biomedical Engineering, University of Texas
Global Bio-Entrepreneurship Course, University of California, San Francisco
Tarun Edwin stands as a trailblazer in the biomedical field, blending visionary invention with strategic expertise to shape the future of medical technology.
Suchit Jacob brings over 15 years of distinguished experience in sales and marketing management, where he has consistently demonstrated leadership and strategic vision. As the driving force behind BIOVIC’s marketing initiatives and acting CFO, he plays a pivotal role in shaping the company's financial and marketing strategies.
With more than 8 years of hands-on experience in biomedical operations, distribution management, pricing reimbursement frameworks, and market intelligence, Suchit is currently focused on the development and expansion of BIOVIC’s Marketing and Sales network, positioning the company for sustained growth and success.
A graduate of Bemidji State University in Minnesota, Suchit holds a Bachelor of Science in Business Administration, which laid the foundation for his exceptional career. His expertise and leadership continue to fuel BIOVIC’s forward momentum in the competitive biomedical landscape.
Scott Pletzer brings over 25 years of unparalleled experience in quality management and engineering, honed through his work with renowned medical device companies such as Becton Dickinson, C.R. Bard, Boston Scientific, and West Pharmaceuticals. A certified ISO 9001:2000 Lead Auditor, Scott possesses an extensive depth of knowledge in Quality System Regulations (QSR), ISO 9001/13485, and the European Medical Device Directive (MDD) requirements.
At BIOVIC, Scott provides invaluable expertise in Quality Management Systems (QMS), guiding the development, scale-up, commercialization, and ongoing maintenance of processes that accelerate time to market while ensuring rigorous regulatory compliance. His leadership has been instrumental in enhancing operational efficiency and ensuring BIOVIC’s commitment to excellence in the biomedical field.
Scott holds a Master of Science in Bioengineering from Clemson University and a Bachelor of Science in Mechanical Engineering from West Virginia University, credentials that reflect his solid foundation in both engineering and biomedical innovation.
Lorri Chavez brings over 20 years of distinguished experience in Regulatory Affairs, orchestrating all regulatory activities at BIOVIC with unparalleled expertise. Her career has spanned several key leadership roles, where her strategic vision and deep understanding of regulatory landscapes have driven success across the biomedical and healthcare sectors.
Her past positions include:
- Senior Regulatory Affairs Manager at Alliance Medical Corporation
- Senior Regulatory Affairs Specialist
at IMPRA Inc.
- Project Manager at
Ethicon Endo-Surgery, Inc.
(a division of Johnson & Johnson)
- Board Director for the National Animal Supplement Council (NASC)
Lorri holds a Bachelor of Science in Liberal Arts from Xavier University and an MBA with a specialization in Healthcare Management from the University of Phoenix. Her unique blend of regulatory acumen and healthcare management expertise has made her an invaluable asset in ensuring BIOVIC’s continued excellence and compliance in an ever-evolving industry.
Rudy Mounia brings over 30 years of extensive experience in the marketing and sales of vascular products, including PTFE grafts, making him a seasoned leader in the field. Throughout his illustrious career, Rudy has contributed to the success of both large medical corporations, such as IMPRA and C.R. Bard, as well as smaller, innovative companies like Vasca and Vascular Flow Technologies. His expertise lies in developing impactful marketing strategies and building high-performing sales teams from the ground up.
At BIOVIC, Rudy plays a crucial role in shaping the company’s global marketing strategy, offering invaluable oversight and direction to ensure its continued growth and success. He will personally lead and coordinate BIOVIC’s U.S. sales and marketing efforts, leveraging his vast experience to drive results and expand the company’s market presence.
Rudy holds a Bachelor of Arts in Marketing Management from Alameda University, equipping him with the knowledge and insight to deliver exceptional strategic leadership in the highly competitive vascular product market.
